ArticleCell death discovery2025

The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis.

Ling Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.